Uneek Mehra - 11 Dec 2023 Form 4 Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Role
CHIEF FINANCIAL & BUSINESS OFFICER
Signature
By: /s/ Scott Bizily as Attorney-in-fact Uneek Mehra
Issuer symbol
FDMT
Transactions as of
11 Dec 2023
Transactions value $
$0
Form type
4
Filing time
13 Dec 2023, 16:05:19 UTC
Previous filing
03 Oct 2023
Next filing
10 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FDMT Stock Option (Right to Buy) Award $0 +75K $0.00 75K 11 Dec 2023 Common Stock 75K $14.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of December 11, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.

Remarks:

CHIEF FINANCIAL & BUSINESS OFFICER